研究資料首頁-> 期刊論文
研究資料明細
| 論文名稱 | Shaping European Union’s global health initiatives. What role for the European Parliament? |
| 發表日期 | 2021-05-30 |
| 論文收錄分類 | SSCI |
| 所有作者 | Vincent Rollet (羅文笙) |
| 作者順序 | 第一作者 |
| 通訊作者 | 否 |
| 刊物名稱 | Journal of Contemporary European Studies (JCES) |
| 發表卷數 | 30 |
| 是否具有審稿制度 | 是 |
| 發表期數 | 1 |
| 期刊或學報出版地國別/地區 | NATGBR-英國 |
| 發表年份 | 2021 |
| 發表月份 | 5 |
| 發表形式 | 紙本及電子期刊 |
| 所屬計劃案 | MOST 107-2410- H-160-007 |
| 可公開文檔 |
|
| 可公開文檔 |
|
| 可公開文檔 |
[摘要] :
This article proposes to assess the role and influence of the European Parliament (EP) in the shaping and implementation of one major instrument of European Union’s (EU’s) global health involvement, namely the European and Developing Countries Clinical Trials Partnership (EDCTP). Through the content analysis of the legislative procedure that led to the establishment and the renewal of this initiative, as well as the EU’s and independent reports that evaluate its implementation, this study examines how EP’s recommendations made at the initial stage of this initiative have been influential for its elaboration and execution. Using an analytical framework designed in the light of the contemporary academic debate on EP’s influence on EU’s foreign policy, this study shows that, despite several challenges, the EP has succeeded in shaping significantly this initiative and its implementation by playing several specific roles. Furthermore, it demonstrates that such influence has made this global health initiative more democratic, more inclusive and more compliant with norms that frame international development cooperation since 2000. Consequently, this article concludes that the EP represents a significant actor of global health governance whose role will be determinant for the elaboration of the future EU–Africa Global Health Partnership (EDCTP-3).
[英文摘要] :
This article proposes to assess the role and influence of the European Parliament (EP) in the shaping and implementation of one major instrument of European Union’s (EU’s) global health involvement, namely the European and Developing Countries Clinical Trials Partnership (EDCTP). Through the content analysis of the legislative procedure that led to the establishment and the renewal of this initiative, as well as the EU’s and independent reports that evaluate its implementation, this study examines how EP’s recommendations made at the initial stage of this initiative have been influential for its elaboration and execution. Using an analytical framework designed in the light of the contemporary academic debate on EP’s influence on EU’s foreign policy, this study shows that, despite several challenges, the EP has succeeded in shaping significantly this initiative and its implementation by playing several specific roles. Furthermore, it demonstrates that such influence has made this global health initiative more democratic, more inclusive and more compliant with norms that frame international development cooperation since 2000. Consequently, this article concludes that the EP represents a significant actor of global health governance whose role will be determinant for the elaboration of the future EU–Africa Global Health Partnership (EDCTP-3).
[參考文獻] :
https://www.tandfonline.com/doi/full/10.1080/14782804.2021.1933399
